As of 2025-05-12, the Fair Value of Lumos Pharma Inc (LUMO) is -20.18 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 4.34 USD, the upside of Lumos Pharma Inc is -565.04%.
With the market price of 4.34 USD and our fair value calculation, Lumos Pharma Inc (LUMO) is not a good investment. Investing in LUMO stocks now will result in a potential loss of 565.04%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 5Y Avg | |
| Net income | -43.00 | -5.70 | -30.40 | -31.10 | -34.03 | -28.85 |
| YoY growth | 19.78% | 86.74% | -433.33% | -2.30% | -9.43% | -67.71% |
| Market Cap (mil) | 37.54 |
| P/E | |
| Forward P/E |
| EPS | -4.04 |
| Avg earnings growth rate | -67.71% |
| TTM earnings | -34.92 |